Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Pars Risk Charts: A 10-Year Study of Risk Assessment for Cardiovascular Diseases in Eastern Mediterranean Region Publisher Pubmed



Sarrafzadegan N1, 2 ; Hassannejad R3 ; Marateb HR4, 5 ; Talaei M1, 6 ; Sadeghi M1 ; Roohafza HR1 ; Masoudkabir F7, 8 ; Oveisgharan S9, 10 ; Mansourian M3 ; Mohebian MR4 ; Mananas MA5, 11
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
  3. 3. Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Biomedical Engineering Department, Engineering Faculty, University of Isfahan, Isfahan, Iran
  5. 5. Department of Automatic Control, Biomedical Engineering Research Center, Universitat Politecnica de Catalunya, BarcelonaTech (UPC), Barcelona, Spain
  6. 6. Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
  7. 7. Department of Cardiology, School of Medicine, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
  8. 8. Cardiac Primary Prevention Research Center, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
  9. 9. Department of Neurology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  10. 10. Rush Alzheimer’s disease Center, Rush University Medical Center, Chicago, Illinois, United States
  11. 11. Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, Spain

Source: PLoS ONE Published:2017


Abstract

[No abstract available]
Related Docs
View other Related Docs
1. Developing Non-Laboratory Cardiovascular Risk Assessment Charts and Validating Laboratory and Non-Laboratory-Based Models, Global Heart (2021)
2. First Iranian Guidelines for the Diagnosis, Management, and Treatment of Hyperlipidemia in Adults, Journal of Research in Medical Sciences (2024)
3. An Office-Based Cardiovascular Prediction Model Developed and Validated in Cohort Studies of a Middle-Income Country, Journal of Clinical Epidemiology (2022)
4. An Evolutionary Machine Learning Algorithm for Cardiovascular Disease Risk Prediction, PLoS ONE (2022)
5. Cardiovascular Disease Risk Prediction Among Iranian Patients With Diabetes Mellitus in Isfahan Province, Iran, in 2014, by Using Framingham Risk Score, Atherosclerotic Cardiovascular Disease Risk Score, and High-Sensitive C-Reactive Protein, ARYA Atherosclerosis (2018)
6. Methods of Sampling and Sample Size Determination of a Comprehensive Integrated Community-Based Interventional Trial: Isfahan Healthy Heart Program, ARYA Atherosclerosis (2018)
7. Anthropometric Indices Predicting Incident Type 2 Diabetes in an Iranian Population: The Isfahan Cohort Study, Diabetes and Metabolism (2013)
8. Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran, International Journal of Health Policy and Management (2022)
Experts (# of related papers)
View all Related Experts
Nizal Sarrafzadegan (107)
Masoumeh Sadeghi (69)
Other Related Docs
9. Left Ventricular Diastolic Function in Subjects With Metabolic Syndrome: Isfahan Cohort Study, Iranian Heart Journal (2013)
10. Does the Impact of Metabolic Syndrome on Cardiovascular Events Vary by Using Different Definitions? Chronic Disease Epidemiology, BMC Public Health (2015)
11. Prognostic Validation of a Non-Laboratory and a Laboratory Based Cardiovascular Disease Risk Score in Multiple Regions of the World, Heart (2018)
12. Longitudinal Association of Dietary Habits and the Risk of Cardiovascular Disease Among Iranian Population Between 2001 and 2013: The Isfahan Cohort Study, Scientific Reports (2023)
13. Cardiovascular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention, Archives of Iranian Medicine (2019)
14. The Isfahan Cohort Study: Rationale, Methods and Main Findings, Journal of Human Hypertension (2011)
15. Isfahan Healthy Heart Program, Sample Size and Sampling Structure: A Comprehensive Report, Journal of Isfahan Medical School (2016)
16. Long-Term Exposure to Pm2.5 and Cardiovascular Disease Incidence and Mortality in an Eastern Mediterranean Country: Findings Based on a 15-Year Cohort Study, Environmental Health: A Global Access Science Source (2021)
17. Anthropometric Indices Predicting Incident Hypertension in an Iranian Population: The Isfahan Cohort Study, Anatolian Journal of Cardiology (2019)
18. Risk and Age of Cardiovascular Event in Women With Metabolic Syndrome: Menopause Age in Focus, Metabolic Syndrome and Related Disorders (2018)
19. Cardiometabolic Risk Factors and Framingham Risk Score in Severely Obese Patients: Baseline Data From Dietbra Trial, Nutrition, Metabolism and Cardiovascular Diseases (2020)
20. The Influence of Gender and Place of Residence on Cardiovascular Diseases and Their Risk Factors. the Isfahan Cohort Study, Saudi Medical Journal (2012)
21. Prevalence and Trends of Vitamin D Deficiency Among Iranian Adults: A Longitudinal Study From 2001–2013, Journal of Nutritional Science and Vitaminology (2017)
22. Cardiovascular Mortality in a Western Asian Country: Results From the Iran Cohort Consortium, BMJ Open (2018)
23. Evaluation of the Relationship Between Hematological Indices and Cardiovascular Events in Isfahan Cohort Study, Avicenna Journal of Clinical Medicine (2021)
24. Longitudinal Association Between an Overall Diet Quality Index and Latent Profiles of Cardiovascular Risk Factors: Results From a Population Based 13-Year Follow up Cohort Study, Nutrition and Metabolism (2021)
25. Multiparity and Risk of Metabolic Syndrome: Isfahan Healthy Heart Program, Metabolic Syndrome and Related Disorders (2009)
26. The Effect of Parental Medical History on the Prevalence of Cerebrovascular Diseases in Their Children in an Iran Ian Population, Basic and Clinical Neuroscience (2018)
27. Prevalence, Awareness, Treatment, Control, and Risk Factors of Hypertension Among Adults: A Cross-Sectional Study in Iran, Epidemiology and Health (2018)
28. Incidence of Cardiovascular Diseases in an Iranian Population: The Isfahan Cohort Study, Archives of Iranian Medicine (2013)
29. Incident Hypertension and Its Predictors: The Isfahan Cohort Study, Journal of Hypertension (2014)
30. Consumption of Sugar-Sweetened Beverages in Relation to the Metabolic Syndrome Among Iranian Adults, Obesity Facts (2012)
31. Dairy Products and Metabolic Syndrome Among Iranian Adult Population: Isfahan Healthy Heart Program, International Dairy Journal (2020)
32. High-Sensitivity C-Reactive Protein and Low-Density Lipoprotein Cholesterol Association With Incident of Cardiovascular Events: Isfahan Cohort Study, BMC Cardiovascular Disorders (2022)
33. Appropriate Cut-Off Values of Waist Circumference to Predict Cardiovascular Outcomes: 7-Year Follow-Up in an Iranian Population, Internal Medicine (2012)
34. Dietary Patterns and Mortality From Cardiovascular Disease: Isfahan Cohort Study, European Journal of Clinical Nutrition (2017)
35. The Impact of a Community Trial on the Pharmacological Treatment in the Individuals With the Metabolic Syndrome: Findings From the Isfahan Healthy Heart Program, 2001-2007, Archives of Medical Science (2012)
36. Persian Registry of Cardiovascular Disease (Prove): Design and Methodology, ARYA Atherosclerosis (2017)
37. Predictors of Metabolic Syndrome in the Iranian Population: Waist Circumference, Body Mass Index, or Waist to Hip Ratio?, Cholesterol (2013)
38. Tea and Coffee Consumption and the 15-Year Risk of Cardiovascular Events: The Isfahan Cohort Study (Ics), Nutrition Journal (2025)
39. Prevalence of Metabolic Syndrome and Its Components in the Iranian Adult Population: A Systematic Review and Meta-Analysis, Iranian Red Crescent Medical Journal (2015)
40. The Impact of Obesity on Hypertension and Diabetes Control Following Healthy Lifestyle Intervention Program in a Developing Country Setting, Journal of Research in Medical Sciences (2011)
41. Correlation of Echocardiographic Epicardial Fat Thickness With Severity of Coronary Artery Disease-An Observational Study; [Koroner Arter Hastaliginin Siddeti Ile Ekokardiyografik Epikardiyal Yag Kalinliginin Iliskisi-Gozlemsel Bir Calisma], Anadolu Kardiyoloji Dergisi (2012)
42. Is Prehypertension a Risk Factors for Cardiovascular Diseases Among Iranian Women?, Journal of Research in Medical Sciences (2012)
43. Longitudinal Association of Metabolic Syndrome and Dietary Patterns: A 13-Year Prospective Population-Based Cohort Study, Nutrition, Metabolism and Cardiovascular Diseases (2018)
44. Validation of a Simplified Food Frequency Questionnaire for the Assessment of Dietary Habits in Iranian Adults: Isfahan Healthy Heart Program, ARYA Atherosclerosis (2015)
45. The Metabolic Syndrome in Hypertensive and Normotensive Subjects: The Isfahan Healthy Heart Programme, Annals of the Academy of Medicine Singapore (2005)
46. Correlation Between Body Fat Distribution, Plasma Lipids and Apolipoproteins With the Severity of Coronary Involvement in Patients With Stable Angina, ARYA Atherosclerosis (2011)
47. Metabolic Syndrome Components and Long-Term Incidence of Cardiovascular Disease in Eastern Mediterranean Region: A 13-Year Population-Based Cohort Study, Metabolic Syndrome and Related Disorders (2019)
48. Healthy Eating Index and Cardiovascular Risk Factors Among Iranians, Journal of the American College of Nutrition (2013)
49. Effect of Psychological Distress on Weight Concern and Weight Control Behaviors, Archives of Iranian Medicine (2014)
50. Heart Rate and Cardiovascular Events: A Nested Case-Control in Isfahan Cohort Study, Archives of Iranian Medicine (2014)